SEC Form 4 · accession 0001209191-15-071060
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Bradbury
Director
Period of report
Sep 15, 2015
Accepted (ET)
Sep 17, 2015 · 12:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Sep 15, 2015 | S | 10,000 | $5.0045 | D | 247,925 | I | BioBrit, LLC |
| Common stockF2 | Sep 16, 2015 | S | 10,000 | $4.9079 | D | 237,925 | I | BioBrit, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Price shown is the average price. Price of the individual blocks sold ranged from $4.96 to $5.08 per share.
- F2Price shown is the average price. Price of the individual blocks sold ranged from $4.75 to $4.98 per share.